[HTML][HTML] A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting stent: the ROLEX study
G Tarantini, LN Fovino, F Varbella, D Trabattoni… - eurointervention.pcronline.com
Background: Data on left main (LM) percutaneous coronary interventions (PCI) have mostly
been obtained in studies using drug-eluting stent (DES) platforms without dedicated large …
been obtained in studies using drug-eluting stent (DES) platforms without dedicated large …
A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting stent: the ROLEX study
G Tarantini, LN Fovino, F Varbella… - …, 2022 - publicatt.unicatt.it
A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting
stent: the ROLEX study IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo …
stent: the ROLEX study IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo …
A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting stent: the ROLEX study.
G Tarantini, LN Fovino, F Varbella… - … : Journal of Europcr in …, 2023 - europepmc.org
Background Data on left main (LM) percutaneous coronary interventions (PCI) have mostly
been obtained in studies using drug-eluting stent (DES) platforms without dedicated large …
been obtained in studies using drug-eluting stent (DES) platforms without dedicated large …
A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting stent: the ROLEX study
G Tarantini, LN Fovino, F Varbella… - …, 2023 - research.unipd.it
Background: Data on left main (LM) percutaneous coronary interventions (PCI) have mostly
been obtained in studies using drug-eluting stent (DES) platforms without dedicated large …
been obtained in studies using drug-eluting stent (DES) platforms without dedicated large …
A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting stent: the ROLEX study
G Tarantini, LN Fovino, F Varbella… - … of EuroPCR in …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Data on left main (LM) percutaneous coronary interventions (PCI) have mostly
been obtained in studies using drug-eluting stent (DES) platforms without dedicated large …
been obtained in studies using drug-eluting stent (DES) platforms without dedicated large …
A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting stent: the ROLEX study
G Tarantini, LN Fovino, F Varbella, D Trabattoni… - …, 2023 - iris.univr.it
Background: Data on left main (LM) percutaneous coronary interventions (PCI) have mostly
been obtained in studies using drug-eluting stent (DES) platforms without dedicated large …
been obtained in studies using drug-eluting stent (DES) platforms without dedicated large …
A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting stent: the ROLEX study
G Tarantini, LN Fovino, F Varbella… - …, 2022 - research.unipd.it
A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting
stent: the ROLEX study IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo …
stent: the ROLEX study IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo …
A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting stent: the ROLEX study.
G Tarantini, LN Fovino, F Varbella… - … : Journal of Europcr in …, 2022 - europepmc.org
Background Data on left main (LM) percutaneous coronary interventions (PCI) have mostly
been obtained in studies using drug-eluting stent (DES) platforms without dedicated large …
been obtained in studies using drug-eluting stent (DES) platforms without dedicated large …